Links

Tools

Export citation

Search in Google Scholar

In-vitro anti-HIV activity of new thiazol-2-ylidene substituted benzamide analogues

Journal article published in 2012 by A. Saeed, N. A. Al Masoudi, C. Pannecouque
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

A new series of N-(5-acetyl-4-methyl-3-(substituted phenyl)-thiazol-2-ylidene)-4-methyl (substituted) benzamides 2a-o was synthesized by heterocyclization of the corresponding 1-substituted benzoyl-3-arylthioureas 1a-o with 3-chloropentane-2,4-dione under microwave irradiation in the absence of any solvent or catalyst. All synthesized compounds have been evaluated for their antiviral activity against the replication of HIV-1 and HIV-2 activity in MT-4. However, compounds 2j and 2n showed activity against HIV-2 with EC 50 of 2.44 μg ml -1 and 1.89 μg ml -1 (CC 50 of 60.68 μg ml -1 and 49.38 μg ml -1), respectively, resulting in a selectivity index of 25 and 26. The results suggest that these compounds can be considered as a new lead in the development of antiviral agents.